de Citigroup Sabra Healthcare REIT SBRA Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 24.7 M | Comprar |
1,267,385
+941,641
| +289% | +USD 18.7 M | 0.01% | 1050 |
|
|
2026
Q1 | USD 6.26 M | Vender |
325,744
-19,179
| -6% | -USD 378 k | ﹤0.01% | 1787 |
|
|
2025
Q4 | USD 6.53 M | Vender |
344,923
-204,846
| -37% | -USD 3.8 M | ﹤0.01% | 1826 |
|
|
2025
Q3 | USD 10.2 M | Comprar |
549,769
+360,619
| +191% | +USD 6.74 M | ﹤0.01% | 1474 |
|
|
2025
Q2 | USD 3.49 M | Vender |
189,150
-133,204
| -41% | -USD 2.36 M | ﹤0.01% | 2193 |
|
|
2025
Q1 | USD 5.63 M | Vender |
322,354
-102,256
| -24% | -USD 1.72 M | ﹤0.01% | 1799 |
|
|
2024
Q4 | USD 7.35 M | Comprar |
424,610
+108,603
| +34% | +USD 1.98 M | ﹤0.01% | 1616 |
|
|
2024
Q3 | USD 5.88 M | Comprar |
316,007
+161,071
| +104% | +USD 2.72 M | ﹤0.01% | 1718 |
|
|
2024
Q2 | USD 2.39 M | Comprar |
154,936
+2,126
| +1% | +USD 30.4 k | ﹤0.01% | 2199 |
|
|
2024
Q1 | USD 2.26 M | Comprar |
152,810
+66,147
| +76% | +USD 916 k | ﹤0.01% | 2347 |
|
|
2023
Q4 | USD 1.24 M | Comprar |
86,663
+14,733
| +20% | +USD 209 k | ﹤0.01% | 2650 |
|
|
2023
Q3 | USD 1 M | Vender |
71,930
-77,452
| -52% | -USD 991 k | ﹤0.01% | 2511 |
|
|
2023
Q2 | USD 1.76 M | Comprar |
149,382
+1,527
| +1% | +USD 17.4 k | ﹤0.01% | 2333 |
|
|
2023
Q1 | USD 1.7 M | Comprar |
147,855
+39,151
| +36% | +USD 484 k | ﹤0.01% | 2128 |
|
|
2022
Q4 | USD 1.35 M | Vender |
108,704
-43,913
| -29% | -USD 560 k | ﹤0.01% | 2352 |
|
|
2022
Q3 | USD 2 M | Comprar |
152,617
+27,532
| +22% | +USD 407 k | ﹤0.01% | 2139 |
|
|
2022
Q2 | USD 1.75 M | Vender |
125,085
-57,238
| -31% | -USD 765 k | ﹤0.01% | 2205 |
|
|
2022
Q1 | USD 2.72 M | Vender |
182,323
-164,256
| -47% | -USD 2.25 M | ﹤0.01% | 2098 |
|
|
2021
Q4 | USD 4.69 M | Vender |
346,579
-18,695
| -5% | -USD 265 k | ﹤0.01% | 1887 |
|
|
2021
Q3 | USD 5.38 M | Vender |
365,274
-70,651
| -16% | -USD 1.19 M | ﹤0.01% | 1776 |
|
|
2021
Q2 | USD 7.93 M | Comprar |
435,925
+142,901
| +49% | +USD 2.54 M | ﹤0.01% | 1577 |
|
|
2021
Q1 | USD 5.09 M | Vender |
293,024
-19,881
| -6% | -USD 350 k | ﹤0.01% | 1776 |
|
|
2020
Q4 | USD 5.44 M | Comprar |
312,905
+35,493
| +13% | +USD 566 k | ﹤0.01% | 2022 |
|
|
2020
Q3 | USD 3.82 M | Comprar |
277,412
+111,303
| +67% | +USD 1.63 M | ﹤0.01% | 2091 |
|
|
2020
Q2 | USD 2.4 M | Vender |
166,109
-16,810
| -9% | -USD 221 k | ﹤0.01% | 2610 |
|
|
2020
Q1 | USD 2 M | Vender |
182,919
-28,718
| -14% | -USD 530 k | ﹤0.01% | 2477 |
|
|
2019
Q4 | USD 4.52 M | Comprar |
211,637
+78,682
| +59% | +USD 1.76 M | ﹤0.01% | 2114 |
|
|
2019
Q3 | USD 3.05 M | Vender |
132,955
-36,826
| -22% | -USD 785 k | ﹤0.01% | 2399 |
|
|
2019
Q2 | USD 3.34 M | Vender |
169,781
-32,599
| -16% | -USD 635 k | ﹤0.01% | 2311 |
|
|
2019
Q1 | USD 3.94 M | Comprar |
202,380
+58,111
| +40% | +USD 1.1 M | ﹤0.01% | 2002 |
|
|
2018
Q4 | USD 2.38 M | Vender |
144,269
-22,431
| -13% | -USD 452 k | ﹤0.01% | 2511 |
|
|
2018
Q3 | USD 3.85 M | Vender |
166,700
-254,521
| -60% | -USD 5.77 M | ﹤0.01% | 2120 |
|
|
2018
Q2 | USD 9.15 M | Vender |
421,221
-154,001
| -27% | -USD 3.01 M | 0.01% | 1349 |
|
|
2018
Q1 | USD 10.2 M | Comprar |
575,222
+449,883
| +359% | +USD 7.93 M | 0.01% | 1225 |
|
|
2017
Q4 | USD 2.35 M | Vender |
125,339
-641,205
| -84% | -USD 12.8 M | ﹤0.01% | 2507 |
|
|
2017
Q3 | USD 16.8 M | Comprar |
766,544
+681,878
| +805% | +USD 15.4 M | 0.01% | 883 |
|
|
2017
Q2 | USD 2.04 M | Comprar |
84,666
+7,508
| +10% | +USD 191 k | ﹤0.01% | 2569 |
|
|
2017
Q1 | USD 2.16 M | Vender |
77,158
-223,555
| -74% | -USD 5.86 M | ﹤0.01% | 2408 |
|
|
2016
Q4 | USD 7.34 M | Comprar |
300,713
+234,756
| +356% | +USD 5.38 M | 0.01% | 1457 |
|
|
2016
Q3 | USD 1.66 M | Comprar |
65,957
+21,249
| +48% | +USD 509 k | ﹤0.01% | 2695 |
|
|
2016
Q2 | USD 923 k | Vender |
44,708
-38,139
| -46% | -USD 795 k | ﹤0.01% | 3047 |
|
|
2016
Q1 | USD 1.66 M | Vender |
82,847
-651,351
| -89% | -USD 12.5 M | ﹤0.01% | 2721 |
|
|
2015
Q4 | USD 14.9 M | Comprar |
734,198
+697,367
| +1,893% | +USD 14.7 M | 0.01% | 893 |
|
|
2015
Q3 | USD 853 k | Comprar |
36,831
+28,221
| +328% | +USD 720 k | ﹤0.01% | 3252 |
|
|
2015
Q2 | USD 222 k | Vender |
8,610
-10,588
| -55% | -USD 301 k | ﹤0.01% | 4356 |
|
|
2015
Q1 | USD 636 k | Vender |
19,198
-24,947
| -57% | -USD 810 k | ﹤0.01% | 3513 |
|
|
2014
Q4 | USD 1.34 M | Comprar |
44,145
+27,071
| +159% | +USD 746 k | ﹤0.01% | 2842 |
|
|
2014
Q3 | USD 415 k | Comprar |
17,074
+6,142
| +56% | +USD 170 k | ﹤0.01% | 3672 |
|
|
2014
Q2 | USD 313 k | Vender |
10,932
-27,168
| -71% | -USD 789 k | ﹤0.01% | 3773 |
|
|
2014
Q1 | USD 1.06 M | Vender |
38,100
-9,058
| -19% | -USD 249 k | ﹤0.01% | 2824 |
|
|
2013
Q4 | USD 1.23 M | Comprar |
47,158
+31,525
| +202% | +USD 813 k | ﹤0.01% | 2985 |
|
|
2013
Q3 | USD 361 k | Vender |
15,633
-2,670
| -15% | -USD 65.8 k | ﹤0.01% | 3698 |
|
|
2013
Q2 | USD 478 k | Comprar |
+18,303
| Nuevas | +USD 528 k | ﹤0.01% | 3517 |
|
Otros fondos que tienen SBRA en su cartera
Posición de Citigroup en SBRA: resumen de T2 2026
Citigroup aumentó su participación en Sabra Healthcare REIT (SBRA) en 289% durante T2 2026, al comprar aproximadamente USD 18.7 M y elevar la posición a 1,267,385 acciones con un valor de USD 24.7 M. La posición representa 0.01% de la cartera y ocupa el puesto #1050.
Citigroup reportó por primera vez una posición en SBRA en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 466 fondos que sigue Wall St. Rank mantienen una posición en SBRA.
- Al cierre de T2 2026, Citigroup tenía 1,267,385 acciones de Sabra Healthcare REIT con un valor de USD 24.7 M.
- Citigroup compró 941,641 acciones de Sabra Healthcare REIT en T2 2026, por un monto estimado de USD 18.7 M.
- Sabra Healthcare REIT representó 0.01% de la cartera de Citigroup en T2 2026 y fue su posición número 1050.
- Citigroup reportó por primera vez una posición en Sabra Healthcare REIT en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 466 fondos que sigue Wall St. Rank tenían Sabra Healthcare REIT en cartera.
Según el Informe 13F de Citigroup correspondiente a T2 2026, presentado el 3 ago 2026.